Viewing Page 3 of 119 | Showing results 21 - 30 of 1187

Fewer hospitalizations for advanced kidney failure patients who choose conservative management

Connie M. Rhee, MD, photographed in white lab coat sitting in front of blue background.
December 06, 2022
IN THE NEWS: Patients with advanced chronic kidney disease who choose conservative management have lower hospitalization rates vs. patients who...

UCI opens clinical trial of stem cell-derived therapy for knee arthritis

November 29, 2022
UCI Health and the UCI Alpha Clinic are conducting the first-in-human clinical trial of a stem cell-derived therapy to treat muscle atrophy...

UCI Health receives another 'A' for patient safety in the Leapfrog Hospital Safety Grade report

A green badge showing an "A" for the fall 2022 Leapfrog Hospital Safety Grade.
November 16, 2022
UCI Health earned its 17th consecutive 'A' in the fall 2022 Leapfrog Hospital Safety Grade. This national distinction, which recognizes a health...

UCI Health and General Catalyst announce unique collaboration to drive digital innovations in healthcare

November 14, 2022
UCI Health has formed a multiyear collaboration with General Catalyst to advance digital transformation that increases the efficiency of healthcare...

2022 UCI Anti-Cancer Challenge raises record $1 million for promising cancer research

Joyous cyclists near the finish line of the 2022 UCI Anti-Cancer Challenge.
November 09, 2022
More than 3,000 participants, donors and supporters who joined the 2022 UCI Anti-Cancer Challenge on Oct. 8 helped raise $1 million for innovative...

UCI tests cell therapy for myasthenia gravis, the first use of CAR T-cells to treat an autoimmune disease

Dr. Tahseen Mozaffar is a board-certified UCI Health neurologist who directs the UCI Health ALS & Neuromuscular Center..
November 08, 2022
UCI Health and the UCI Alpha Clinic are conducting a clinical trial of an investigational cell therapy in patients with generalized myasthenia...

UCI Health honored for surgical safety and excellence

UCI Health Chief Medical Officer Joseph C. Carmichael, MD.
November 04, 2022
UCI Health has again been recognized by the American College of Surgeons as achieving "meritorious outcomes for surgical patient care. UCI Medical...

UCI opens first natural killer cell clinical trial for recurrent glioblastoma

Dr. Daniela Bota, a UCI Health neuro-oncologist and director of the UCI Alpha Clinic, the clinical trials arm of the UCI Sue and Bill Gross Stem Cell Research Center.
November 04, 2022
UCI Health and the UCI Alpha Clinic have opened the first clinical trial to assess the safety and effectiveness of natural killer cell therapy in...

$8 million grant expands access to UCI stem cell clinical trials

November 03, 2022
IN THE NEWS: An $8 million grant and designation as one of the state's network of stem cell therapy clinics is enabling UC Irvine to expand patient...

UCI Health pediatrician leads efforts to test RSV vaccine

November 01, 2022
IN THE NEWS: A UCI Health pediatric infectious disease expert describes research underway on a vaccine for respiratory syncytial virus (RSV), a...

View by Category